The Changing Landscape of IBDEmerging Concepts in Patient Management
Effect of tight control management on Crohn’s disease (CALM): a multicentre, randomised, controlled phase 3 trial.
Colombel JF, et al. Lancet. 2018;390(10114):2779-2789.
Coskun M, et al. Pharmacol Res. 2013;76:1-8.
Kim DH, Cheon JH. Immune Netw. 2017;17(1):25-40.
De Vries LCS, et al. J Crohns Colitis. 2017;11(7):885-893.
Olivera P, et al. Expert Rev Clin Immunol. 2017;13(7):693-703.
Sandborn WJ, et al. N Engl J Med. 2017;377(5):496-497.
Clinical remission in patients with moderate-to-severe Crohn’s disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial.
Vermeire S, et al. Lancet. 2017;389(10066):266-275.
Emerging Concepts in Patient Management
Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV
Advances in the Diagnosis and Treatment of Nonalcoholic Steatohepatitis
Got it? Treat it!
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.
The Emerging Role of the Diabetologist
Key Issues Impacting OB/GYN Practice
An Interactive Experience Highlighting Recent Clinical Advances
Hot Topics in HBV, HCV, and NASH
Building Your Understanding to Combat a Growing Problem